COVID-19 Vaccine Prices Capped at Private Hospitals, Here is How Much it Will Cost Now
Published On Jun 09, 2021 10:00 AM By Sakshi Aggarwal
The Union Health Ministry announced capped prices of COVID-19 vaccines in private hospitals, on Tuesday. The price capping has come into the scene after PM Narendra Modi addressed the nation on Monday, in which he announced about reversing the government’s policy and that the government will provide free vaccines to all. PM Modi said that free vaccines will be provided to the states for inoculation of people aged above years, from June.
The maximum price for Covaxin and Covishield is fixed at Rs. 1,410 and Rs. 780 per dose respectively in private hospitals. Whereas the price for Russia’s Sputnik V vaccine has been fixed at Rs. 1,145 per dose. The Health Ministry made it clear that appropriate strict action will be taken against private vaccination centers in case of overcharging, via a letter to all the states and UTs. The Health Ministry also requested states and union territories to regularly check the prices that private centers are charging the citizens. Further, the service charges by private hospitals are also capped at Rs. 150 per dose.
Earlier today, the center announced that it has ordered 25 crore doses of the Covishield vaccine and 19 crore doses of Covaxin. As per the Union Ministry, all these COVID-19 vaccines will be delivered by their makers between August and December 2021. Also, it stated that a 30% advance has been released to the Serum Institute of India and Bharat Biotech, for procurement of the vaccines.
The government has also placed an order to buy 30 crore doses of Biological E’s vaccine, which will be available by September, as shared during a press briefing by Dr. VK Paul, who is a member-Health, Niti Ayog.
You May Also Like to Read: Center Issues Vaccination SOPs to People For People Travelling Abroad for Work, Studies
Antibody Cocktail: All You Need to Know
Will My Second Dose Vaccination Appointment Be Automatically Scheduled By CoWIN System?
Disclaimer: This article is issued in the general public interest and meant for general information purposes only. Readers are advised not to rely on the contents of the article as conclusive in nature and should research further or consult an expert in this regard.